Key molecular scaffolds in the development of clinically viable α-amylase inhibitors.
Sign Up to like & getrecommendations! Published in 2025 at "Future medicinal chemistry"
DOI: 10.1080/17568919.2025.2453421
Abstract: The escalating cases of type II diabetes combined with adverse side effects of current antidiabetic drugs spurred the advancement of innovative approaches for the management of postprandial glucose levels. α-Amylase is an endoamylase responsible for… read more here.
Keywords: amylase; molecular scaffolds; key molecular; scaffolds development ... See more keywords
1,2,4- and 1,3,4-Oxadiazoles as Scaffolds in the Development of Antiparasitic Agents
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Brazilian Chemical Society"
DOI: 10.21577/0103-5053.20170208
Abstract: In this review, we present the potential use of the heterocyclic oxadiazole rings in the design and synthesis of new drugs to treat parasitic infections. We intend to compare herein all the four isomeric forms… read more here.
Keywords: antiparasitic agents; scaffolds development; oxadiazoles scaffolds; development antiparasitic ... See more keywords
Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents.
Sign Up to like & getrecommendations! Published in 2017 at "Current medicinal chemistry"
DOI: 10.2174/0929867324666170316120304
Abstract: The lack of specificity of traditional cytotoxic drugs triggers the development of anticancer agents with high selectivity to tumor-specific proteins. The unveiling of target structures such as EGFR or Her2 allows the focused development of… read more here.
Keywords: scaffolds development; multicyclic peptides; development; display techniques ... See more keywords